Can drug price hikes via debranding be prevented?

Bokhari, Farasat and Lyons, Bruce (2017) Can drug price hikes via debranding be prevented? Prescriber, 28 (4). pp. 44-46.

Preview

PDF (Accepted manuscript) - Accepted Version Download (175kB) | Preview

Abstract

Steep price hikes following the debranding of off-patent medicines are becoming increasingly common in the UK, adding hundreds of millions to the NHS drugs bill. But can anything be done to prevent this?

Item Type:	Article
Faculty \ School:	Faculty of Social Sciences > School of Economics
UEA Research Groups:	Faculty of Social Sciences > Research Groups > Industrial Economics Faculty of Social Sciences > Research Centres > Centre for Competition Policy
Related URLs:	http://onlinelibrary.wiley.com/doi/10.10...
Depositing User:	Pure Connector
Date Deposited:	12 May 2017 05:05
Last Modified:	28 Jun 2025 00:29
URI:	https://ueaeprints.uea.ac.uk/id/eprint/63483
DOI:	10.1002/psb.1563

Downloads

Actions (login required)

View Item